Mode
Text Size
Log in / Sign up
N/A N=546 Randomized Triple-blind Treatment

Evaluation of Gluma Desensitizer in Post-treatment Sensitivity in Posterior Composite

Sensitivity, Tooth

Enrolled (actual)
546
Serious AEs
0.0%
Results posted
Oct 2025
Primary outcome: Primary: Number of Participants With Post-operative Sensitivity Having VAS Score >3 — 14; 12; 6; 16 Participants — p=0.05

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
GLUMA (Kulzer GmbH, Germany) desensitizing agent (Other)
Age
Pediatric, Adult, Older Adult · 15+ yrs
Sex
All
Sponsor
Tamil Nadu Dr.M.G.R.Medical University
Primary completion
Feb 2025

Outcome Measures

OutcomeResultp-value
PRIMARY
Number of Participants With Post-operative Sensitivity Having VAS Score >3
6; 12; 3; 9; 2; 12
PRIMARY
Number of Participants With Post-operative Sensitivity Having VAS Score >3
6; 12; 3; 9; 2; 12
PRIMARY
Number of Participants With Post-operative Sensitivity Having VAS Score >3
6; 12; 3; 9; 2; 12
SECONDARY
Number of Participants With Stimulus Based/ Spontaneous Post-operative Sensitivity Having VAS Score >3
6; 6; 6; 7; 2; 2
SECONDARY
Number of Participants With Stimulus Based/ Spontaneous Post-operative Sensitivity Having VAS Score >3
6; 6; 6; 7; 2; 2
SECONDARY
Number of Participants With Stimulus Based/ Spontaneous Post-operative Sensitivity Having VAS Score >3
6; 6; 6; 7; 2; 2

Summary

To evaluate the effect of Gluma desensitizer in controlling immediate post-treatment sensitivity in posterior occlusal composite restorations.

Eligibility Criteria

Inclusion Criteria

  • Occlusal cavitated caries in maxillary and mandibular first and second molars

Exclusion Criteria

  • Occlusal caries with axial or proximal extension
  • Teeth with periodontal treatment within last three months
  • Teeth with cracks
  • Teeth to be taken as abutment for prosthesis
  • Patients with psychiatric treatment
  • Patients in orthodontic treatment or going to need orthodontic treatment
  • Patients under dentin hypersensitivity or using desensitizer treatment
  • Patients not willing for post treatment follow up
  • Patients having any other teeth with pain or sensitivity symptoms
  • Caries excavation with pulp exposure and post treatment sensitivity due to occusal interference in restoration
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04248803). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search